投稿ビュー
An expanded label for Amarin's fish-oil drug looks more likely, but how fast will profits - STAT
An expanded label for Amarin's fish-oil drug looks more likely, but how fast will profits STAT
The company says the FDA is “unlikely” to convene an advisory committee meeting to review data on an expanded use of its heart drug Vascepa.
投稿情報
31.07.2019 (2114日前)
評価
おすすめ
タグ
転職
"
"@type":
"@type":"NewsArticle"
"Auga Group"
"C" grade Nevada infrastructure
"Errol Oh"
"Jane Goodyear"
"Optimistically Cautious"
"a man and his prostate"
"akcijų pardavimas"
"analytics:simplereach:id":"54
"author":"Art Berman"
"author":"Brad McMillan"
"author":"Bryan Rich"
"author":"Christopher Helman"
"author":"Claire Poole"
"author":"Clare O'Connor"
"author":"David Blackmon"
